Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Using budding yeast to screen for anti-prion drugs.
Tribouillard D, Bach S, Gug F, Desban N, Beringue V, Andrieu T, Dormont D, Galons H, Laude H, Vilette D, Blondel M. Tribouillard D, et al. Among authors: beringue v. Biotechnol J. 2006 Jan;1(1):58-67. doi: 10.1002/biot.200500001. Biotechnol J. 2006. PMID: 16892225
Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs.
Tribouillard-Tanvier D, Dos Reis S, Gug F, Voisset C, Béringue V, Sabate R, Kikovska E, Talarek N, Bach S, Huang C, Desban N, Saupe SJ, Supattapone S, Thuret JY, Chédin S, Vilette D, Galons H, Sanyal S, Blondel M. Tribouillard-Tanvier D, et al. Among authors: beringue v. PLoS One. 2008 May 14;3(5):e2174. doi: 10.1371/journal.pone.0002174. PLoS One. 2008. PMID: 18478094 Free PMC article.
Prion agent diversity and species barrier.
Béringue V, Vilotte JL, Laude H. Béringue V, et al. Vet Res. 2008 Jul-Aug;39(4):47. doi: 10.1051/vetres:2008024. Epub 2008 Jun 3. Vet Res. 2008. PMID: 18519020 Free article. Review.
Mammalian prions: tolerance to sequence changes-how far?
Salamat MK, Munoz-Montesino C, Moudjou M, Rezaei H, Laude H, Béringue V, Dron M. Salamat MK, et al. Among authors: beringue v. Prion. 2013 Mar-Apr;7(2):131-5. doi: 10.4161/pri.23110. Epub 2012 Dec 11. Prion. 2013. PMID: 23232499 Free PMC article. Review.
The toll-like receptor agonist imiquimod is active against prions.
Oumata N, Nguyen PH, Beringue V, Soubigou F, Pang Y, Desban N, Massacrier C, Morel Y, Paturel C, Contesse MA, Bouaziz S, Sanyal S, Galons H, Blondel M, Voisset C. Oumata N, et al. Among authors: beringue v. PLoS One. 2013 Aug 16;8(8):e72112. doi: 10.1371/journal.pone.0072112. eCollection 2013. PLoS One. 2013. PMID: 23977222 Free PMC article.
Structure-activity relationship study around guanabenz identifies two derivatives retaining antiprion activity but having lost α2-adrenergic receptor agonistic activity.
Nguyen PH, Hammoud H, Halliez S, Pang Y, Evrard J, Schmitt M, Oumata N, Bourguignon JJ, Sanyal S, Beringue V, Blondel M, Bihel F, Voisset C. Nguyen PH, et al. Among authors: beringue v. ACS Chem Neurosci. 2014 Oct 15;5(10):1075-82. doi: 10.1021/cn5001588. Epub 2014 Sep 22. ACS Chem Neurosci. 2014. PMID: 25244284
Getting to the core of prion superstructural variability.
Torrent J, Lange R, Igel-Egalon A, Béringue V, Rezaei H. Torrent J, et al. Among authors: beringue v. Prion. 2016;10(1):1-8. doi: 10.1080/19336896.2015.1122161. Prion. 2016. PMID: 26636374 Free PMC article.
118 results